QA: Cambrex CORP in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000820081_2016_Cambrex_CORP.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000820081, Cambrex CORP

  xvar xval
0 AssetsCurrent 259,279,000
1 IntangibleAssetsNetIncludingGoodwill 38,754,000
2 PropertyPlantAndEquipmentNet 186,487,000
3 remainder_Assets 21,019,000
4 LiabilitiesCurrent 129,802,000
5 LiabilitiesNoncurrent 14,506,000
6 remainder_Liabilities 50,396,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 57,867,000
9 ResearchAndDevelopmentExpense 12,540,000
10 remainder_Expenses 304,323,000
11 remainder_Revenues 433,326,000
12 remainder_NetIncome -1,379,000
13 remainder_ComprehensiveNetIncome -10,468,000
  yvar yval
0 Assets 505,539,000
1 Liabilities 194,704,000
2 Expenses 374,730,000
3 Revenues 433,326,000
4 StockholdersEquity 310,835,000
5 NetIncome 57,217,000
6 ComprehensiveNetIncome 51,983,000
7 BaseVar 760,073,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.08
9 EconomicCapitalRatio 3.08

Edgar->Model Mapping

Feature Distribution

Change over Time